Title of article :
Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: Analysis of CK20, CD44, P53 and Ki67
Author/Authors :
Asgari, Mojgan. Oncopathology Research Center and Hasheminejad Clinical Research Developing Center (HCRDC) - Iran University of Medical Sciences, Tehran, Iran , Nabi Maybodi, Mahtab Iran University of Medical Sciences, Tehran, Iran , Abolhasani, Maryam Oncopathology Research Center and Hasheminejad Clinical Research Developing Center - Iran University of Medical Sciences, Tehran, Iran
Abstract :
Background: Flat urothelial lesions comprise a spectrum of morphologic changes ranging from reactive atypia
to carcinoma in situ (CIS). Urothelial dysplasia and CIS are associated with the recurrence and progression of
urothelial carcinoma. Distinguishing CIS and dysplasia from reactive atypia based on histolopathogical features
alone is often difficult. Using different immunohistochemical markers such as Cytokeratin 20 (CK20), CD44,
p53, and Ki-67 is recommended for differential diagnosis. The aim of this study was to evaluate the immunohistochemical
pattern of these antibodies to differentiate different flat urothelial lesions.
Methods: In this cross- sectional study, three groups of bladder biopsy specimens were evaluated: 20 samples
with reactive urothelial lesions, 20 histologically diagnosed as CIS, and 20 morphologically normal samples.
Immunohistochemical staining of CK20, p53, CD44 and Ki-67 markers was performed on paraffin-embedded
blocks. The groups were compared using chi square test, and the diagnostic value of the markers were evaluated
with sensitivity, specificity, positive and negative predictive values.
Results: CK20 was full thickness positive in 15 (75%) CIS samples and negative in all samples of the normal
and reactive groups (p<0.001); CD44 was positive in 2 (10%) cases of the CIS group and in 17 (85%) of the
reactive group; this marker was negative in all the normal samples (p<0.001). P53 was positive in 12 (60%)
samples of the CIS group and negative in all samples of the normal and reactive groups (p<0.001). Ki67 was
positive in 13 (65%) samples of the CIS group and 1 (5%) sample of the reactive group. This marker was negative
in all samples of the normal group (p<0.001).
Conclusion: The results of this study revealed that CK20, CD44, P53 and Ki67 are useful in distinguishing
CIS from reactive and normal samples. However, they should be used in a panel including at least three markers.
Correlation with the morphologic features is necessary.
Keywords :
P53 and Ki67 , CD44 , CK20 , Urothelial Carcinoma in Situ , Urothelium
Journal title :
Astroparticle Physics